home / stock / btai / btai quote
Last: | $2.63 |
---|---|
Change Percent: | 0.0% |
Open: | $2.61 |
Close: | $2.63 |
High: | $2.65 |
Low: | $2.52 |
Volume: | 260,016 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.63 | $2.61 | $2.63 | $2.65 | $2.52 | 260,016 | 04-26-2024 |
$2.61 | $2.72 | $2.61 | $2.72 | $2.55 | 665,832 | 04-25-2024 |
$2.71 | $2.97 | $2.71 | $2.99 | $2.66 | 879,848 | 04-24-2024 |
$2.97 | $2.84 | $2.97 | $3.045 | $2.7933 | 408,064 | 04-23-2024 |
$2.85 | $2.73 | $2.85 | $2.86 | $2.6 | 369,752 | 04-22-2024 |
$2.75 | $2.55 | $2.75 | $2.79 | $2.52 | 619,867 | 04-19-2024 |
$2.55 | $2.57 | $2.55 | $2.6314 | $2.55 | 244,533 | 04-18-2024 |
$2.59 | $2.72 | $2.59 | $2.75 | $2.58 | 319,973 | 04-17-2024 |
$2.68 | $2.76 | $2.68 | $2.78 | $2.64 | 229,750 | 04-16-2024 |
$2.75 | $2.89 | $2.75 | $2.9713 | $2.71 | 477,237 | 04-15-2024 |
$2.9 | $2.78 | $2.9 | $3.099 | $2.775 | 1,130,764 | 04-12-2024 |
$2.79 | $2.67 | $2.79 | $2.8083 | $2.5811 | 341,944 | 04-11-2024 |
$2.63 | $2.63 | $2.63 | $2.68 | $2.58 | 390,462 | 04-10-2024 |
$2.57 | $2.58 | $2.57 | $2.66 | $2.55 | 364,817 | 04-09-2024 |
$2.63 | $2.68 | $2.63 | $2.71 | $2.62 | 160,511 | 04-08-2024 |
$2.66 | $2.67 | $2.66 | $2.7 | $2.6 | 186,688 | 04-05-2024 |
$2.69 | $2.63 | $2.69 | $2.69 | $2.565 | 423,803 | 04-04-2024 |
$2.64 | $2.67 | $2.64 | $2.6701 | $2.57 | 307,950 | 04-03-2024 |
$2.64 | $2.76 | $2.64 | $2.78 | $2.56 | 528,422 | 04-02-2024 |
$2.82 | $2.82 | $2.82 | $2.86 | $2.72 | 317,338 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
NEW HAVEN, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its first quarter 2024 financ...
Poster presentation scheduled for June 1, 2024, 1:30-4:30 PM CT /2:30-5:30 PM ET Trial being led by Georgetown University's Lombardi Comprehe...
Poster presentation scheduled for June 1, 2024, 1:30-4:30 PM CT /2:30-5:30 PM ET Trial being led by Georgetown University’s Lombardi Comprehensive Cancer Center NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmace...